Test your knowledge on approved biologics in the management of moderate to severe atopic dermatitis and considerations for an 18-year-old man's case.
The vast treatment landscape to treat atopic dermatitis (AD) requires transparency and shared decision making with patients. Peter Lio, MD, and April Armstrong, MD, MPH, led a session at the 2023 Fall Clinical Dermatology Conference focusing on the biologic options available.1
Test your knowledge of the condition, the biologic treatment landscape, and considerations in the case of an 18-year-old man.
What is the prevalence of AD in children and adults?